Global Organ Transplant Immunosuppreant Market Size, Status and Forecast 2020-2026

May 2020 | 128 pages | ID: GEB891BDE7B8EN
QYResearch

Abstracts

This report focuses on the global Organ Transplant Immunosuppreant status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Organ Transplant Immunosuppreant development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Astellas Pharma
• Roche
• Novartis
• Wyeth(Pfizer)
• GlaxoSmithKline
• Genzyme (Sanofi)
• Huadong Pharmaceutical
• North China Pharmaceutical Huasheng Co.
• Hisun
• SL PHARM
• Nanjing Hicin
• Hongsheng
• CINKATE CORPORATION
• Huitian
• Sinopharm ChuanKang Pharmaceutical

Market segment by Type, the product can be split into

• Selective Inhibitor of Cytokine Production And Function
• Immunosuppressive Antimetabolites
• Immunosuppressive Antibodies
• Immunosuppressive Adrenocorticosteroids

Market segment by Application, split into

• Kidney Transplantation
• Liver Transplantation
• Heart Transplantation
• Lung Transplantation
• Pancreas Transplantation

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Organ Transplant Immunosuppreant status, future forecast, growth opportunity, key market and key players.
• To present the Organ Transplant Immunosuppreant development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Organ Transplant Immunosuppreant are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Organ Transplant Immunosuppreant Revenue
1.4 Market Analysis by Type
  1.4.1 Global Organ Transplant Immunosuppreant Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Selective Inhibitor of Cytokine Production And Function
  1.4.3 Immunosuppressive Antimetabolites
  1.4.4 Immunosuppressive Antibodies
  1.4.5 Immunosuppressive Adrenocorticosteroids
1.5 Market by Application
  1.5.1 Global Organ Transplant Immunosuppreant Market Share by Application: 2020 VS 2026
  1.5.2 Kidney Transplantation
  1.5.3 Liver Transplantation
  1.5.4 Heart Transplantation
  1.5.5 Lung Transplantation
  1.5.6 Pancreas Transplantation
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Organ Transplant Immunosuppreant Market Perspective (2015-2026)
2.2 Organ Transplant Immunosuppreant Growth Trends by Regions
  2.2.1 Organ Transplant Immunosuppreant Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Organ Transplant Immunosuppreant Historic Market Share by Regions (2015-2020)
  2.2.3 Organ Transplant Immunosuppreant Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Organ Transplant Immunosuppreant Market Growth Strategy
  2.3.6 Primary Interviews with Key Organ Transplant Immunosuppreant Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Organ Transplant Immunosuppreant Players by Market Size
  3.1.1 Global Top Organ Transplant Immunosuppreant Players by Revenue (2015-2020)
  3.1.2 Global Organ Transplant Immunosuppreant Revenue Market Share by Players (2015-2020)
  3.1.3 Global Organ Transplant Immunosuppreant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Organ Transplant Immunosuppreant Market Concentration Ratio
  3.2.1 Global Organ Transplant Immunosuppreant Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Organ Transplant Immunosuppreant Revenue in 2019
3.3 Organ Transplant Immunosuppreant Key Players Head office and Area Served
3.4 Key Players Organ Transplant Immunosuppreant Product Solution and Service
3.5 Date of Enter into Organ Transplant Immunosuppreant Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Organ Transplant Immunosuppreant Historic Market Size by Type (2015-2020)
4.2 Global Organ Transplant Immunosuppreant Forecasted Market Size by Type (2021-2026)

5 ORGAN TRANSPLANT IMMUNOSUPPREANT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Organ Transplant Immunosuppreant Market Size by Application (2015-2020)
5.2 Global Organ Transplant Immunosuppreant Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Organ Transplant Immunosuppreant Market Size (2015-2020)
6.2 Organ Transplant Immunosuppreant Key Players in North America (2019-2020)
6.3 North America Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
6.4 North America Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Organ Transplant Immunosuppreant Market Size (2015-2020)
7.2 Organ Transplant Immunosuppreant Key Players in Europe (2019-2020)
7.3 Europe Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
7.4 Europe Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

8 CHINA

8.1 China Organ Transplant Immunosuppreant Market Size (2015-2020)
8.2 Organ Transplant Immunosuppreant Key Players in China (2019-2020)
8.3 China Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
8.4 China Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Organ Transplant Immunosuppreant Market Size (2015-2020)
9.2 Organ Transplant Immunosuppreant Key Players in Japan (2019-2020)
9.3 Japan Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
9.4 Japan Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Organ Transplant Immunosuppreant Market Size (2015-2020)
10.2 Organ Transplant Immunosuppreant Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
10.4 Southeast Asia Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

11 INDIA

11.1 India Organ Transplant Immunosuppreant Market Size (2015-2020)
11.2 Organ Transplant Immunosuppreant Key Players in India (2019-2020)
11.3 India Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
11.4 India Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Organ Transplant Immunosuppreant Market Size (2015-2020)
12.2 Organ Transplant Immunosuppreant Key Players in Central & South America (2019-2020)
12.3 Central & South America Organ Transplant Immunosuppreant Market Size by Type (2015-2020)
12.4 Central & South America Organ Transplant Immunosuppreant Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astellas Pharma
  13.1.1 Astellas Pharma Company Details
  13.1.2 Astellas Pharma Business Overview and Its Total Revenue
  13.1.3 Astellas Pharma Organ Transplant Immunosuppreant Introduction
  13.1.4 Astellas Pharma Revenue in Organ Transplant Immunosuppreant Business (2015-2020))
  13.1.5 Astellas Pharma Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Organ Transplant Immunosuppreant Introduction
  13.2.4 Roche Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Organ Transplant Immunosuppreant Introduction
  13.3.4 Novartis Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.3.5 Novartis Recent Development
13.4 Wyeth(Pfizer)
  13.4.1 Wyeth(Pfizer) Company Details
  13.4.2 Wyeth(Pfizer) Business Overview and Its Total Revenue
  13.4.3 Wyeth(Pfizer) Organ Transplant Immunosuppreant Introduction
  13.4.4 Wyeth(Pfizer) Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.4.5 Wyeth(Pfizer) Recent Development
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Details
  13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline Organ Transplant Immunosuppreant Introduction
  13.5.4 GlaxoSmithKline Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.5.5 GlaxoSmithKline Recent Development
13.6 Genzyme (Sanofi)
  13.6.1 Genzyme (Sanofi) Company Details
  13.6.2 Genzyme (Sanofi) Business Overview and Its Total Revenue
  13.6.3 Genzyme (Sanofi) Organ Transplant Immunosuppreant Introduction
  13.6.4 Genzyme (Sanofi) Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.6.5 Genzyme (Sanofi) Recent Development
13.7 Huadong Pharmaceutical
  13.7.1 Huadong Pharmaceutical Company Details
  13.7.2 Huadong Pharmaceutical Business Overview and Its Total Revenue
  13.7.3 Huadong Pharmaceutical Organ Transplant Immunosuppreant Introduction
  13.7.4 Huadong Pharmaceutical Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.7.5 Huadong Pharmaceutical Recent Development
13.8 North China Pharmaceutical Huasheng Co.
  13.8.1 North China Pharmaceutical Huasheng Co. Company Details
  13.8.2 North China Pharmaceutical Huasheng Co. Business Overview and Its Total Revenue
  13.8.3 North China Pharmaceutical Huasheng Co. Organ Transplant Immunosuppreant Introduction
  13.8.4 North China Pharmaceutical Huasheng Co. Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.8.5 North China Pharmaceutical Huasheng Co. Recent Development
13.9 Hisun
  13.9.1 Hisun Company Details
  13.9.2 Hisun Business Overview and Its Total Revenue
  13.9.3 Hisun Organ Transplant Immunosuppreant Introduction
  13.9.4 Hisun Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.9.5 Hisun Recent Development
13.10 SL PHARM
  13.10.1 SL PHARM Company Details
  13.10.2 SL PHARM Business Overview and Its Total Revenue
  13.10.3 SL PHARM Organ Transplant Immunosuppreant Introduction
  13.10.4 SL PHARM Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  13.10.5 SL PHARM Recent Development
13.11 Nanjing Hicin
  10.11.1 Nanjing Hicin Company Details
  10.11.2 Nanjing Hicin Business Overview and Its Total Revenue
  10.11.3 Nanjing Hicin Organ Transplant Immunosuppreant Introduction
  10.11.4 Nanjing Hicin Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  10.11.5 Nanjing Hicin Recent Development
13.12 Hongsheng
  10.12.1 Hongsheng Company Details
  10.12.2 Hongsheng Business Overview and Its Total Revenue
  10.12.3 Hongsheng Organ Transplant Immunosuppreant Introduction
  10.12.4 Hongsheng Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  10.12.5 Hongsheng Recent Development
13.13 CINKATE CORPORATION
  10.13.1 CINKATE CORPORATION Company Details
  10.13.2 CINKATE CORPORATION Business Overview and Its Total Revenue
  10.13.3 CINKATE CORPORATION Organ Transplant Immunosuppreant Introduction
  10.13.4 CINKATE CORPORATION Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  10.13.5 CINKATE CORPORATION Recent Development
13.14 Huitian
  10.14.1 Huitian Company Details
  10.14.2 Huitian Business Overview and Its Total Revenue
  10.14.3 Huitian Organ Transplant Immunosuppreant Introduction
  10.14.4 Huitian Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  10.14.5 Huitian Recent Development
13.15 Sinopharm ChuanKang Pharmaceutical
  10.15.1 Sinopharm ChuanKang Pharmaceutical Company Details
  10.15.2 Sinopharm ChuanKang Pharmaceutical Business Overview and Its Total Revenue
  10.15.3 Sinopharm ChuanKang Pharmaceutical Organ Transplant Immunosuppreant Introduction
  10.15.4 Sinopharm ChuanKang Pharmaceutical Revenue in Organ Transplant Immunosuppreant Business (2015-2020)
  10.15.5 Sinopharm ChuanKang Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Organ Transplant Immunosuppreant Key Market Segments
Table 2. Key Players Covered: Ranking by Organ Transplant Immunosuppreant Revenue
Table 3. Ranking of Global Top Organ Transplant Immunosuppreant Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Organ Transplant Immunosuppreant Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Selective Inhibitor of Cytokine Production And Function
Table 6. Key Players of Immunosuppressive Antimetabolites
Table 7. Key Players of Immunosuppressive Antibodies
Table 8. Key Players of Immunosuppressive Adrenocorticosteroids
Table 9. Global Organ Transplant Immunosuppreant Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Organ Transplant Immunosuppreant Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Organ Transplant Immunosuppreant Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Organ Transplant Immunosuppreant Market Share by Regions (2015-2020)
Table 13. Global Organ Transplant Immunosuppreant Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Organ Transplant Immunosuppreant Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Organ Transplant Immunosuppreant Market Growth Strategy
Table 19. Main Points Interviewed from Key Organ Transplant Immunosuppreant Players
Table 20. Global Organ Transplant Immunosuppreant Revenue by Players (2015-2020) (Million US$)
Table 21. Global Organ Transplant Immunosuppreant Market Share by Players (2015-2020)
Table 22. Global Top Organ Transplant Immunosuppreant Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppreant as of 2019)
Table 23. Global Organ Transplant Immunosuppreant by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Organ Transplant Immunosuppreant Product Solution and Service
Table 26. Date of Enter into Organ Transplant Immunosuppreant Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 29. Global Organ Transplant Immunosuppreant Market Size Share by Type (2015-2020)
Table 30. Global Organ Transplant Immunosuppreant Revenue Market Share by Type (2021-2026)
Table 31. Global Organ Transplant Immunosuppreant Market Size Share by Application (2015-2020)
Table 32. Global Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 33. Global Organ Transplant Immunosuppreant Market Size Share by Application (2021-2026)
Table 34. North America Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 36. North America Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 37. North America Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 38. North America Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 39. North America Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 40. Europe Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 42. Europe Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 44. Europe Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 46. China Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 47. China Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 48. China Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 49. China Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 50. China Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 51. China Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 52. Japan Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 54. Japan Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 56. Japan Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 60. Southeast Asia Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 62. Southeast Asia Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 64. India Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 65. India Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 66. India Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 67. India Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 68. India Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 69. India Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Organ Transplant Immunosuppreant Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Organ Transplant Immunosuppreant Market Share (2019-2020)
Table 72. Central & South America Organ Transplant Immunosuppreant Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Organ Transplant Immunosuppreant Market Share by Type (2015-2020)
Table 74. Central & South America Organ Transplant Immunosuppreant Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Organ Transplant Immunosuppreant Market Share by Application (2015-2020)
Table 76. Astellas Pharma Company Details
Table 77. Astellas Pharma Business Overview
Table 78. Astellas Pharma Product
Table 79. Astellas Pharma Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 80. Astellas Pharma Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Wyeth(Pfizer) Company Details
Table 92. Wyeth(Pfizer) Business Overview
Table 93. Wyeth(Pfizer) Product
Table 94. Wyeth(Pfizer) Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 95. Wyeth(Pfizer) Recent Development
Table 96. GlaxoSmithKline Company Details
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 100. GlaxoSmithKline Recent Development
Table 101. Genzyme (Sanofi) Company Details
Table 102. Genzyme (Sanofi) Business Overview
Table 103. Genzyme (Sanofi) Product
Table 104. Genzyme (Sanofi) Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 105. Genzyme (Sanofi) Recent Development
Table 106. Huadong Pharmaceutical Company Details
Table 107. Huadong Pharmaceutical Business Overview
Table 108. Huadong Pharmaceutical Product
Table 109. Huadong Pharmaceutical Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 110. Huadong Pharmaceutical Recent Development
Table 111. North China Pharmaceutical Huasheng Co. Business Overview
Table 112. North China Pharmaceutical Huasheng Co. Product
Table 113. North China Pharmaceutical Huasheng Co. Company Details
Table 114. North China Pharmaceutical Huasheng Co. Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 115. North China Pharmaceutical Huasheng Co. Recent Development
Table 116. Hisun Company Details
Table 117. Hisun Business Overview
Table 118. Hisun Product
Table 119. Hisun Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 120. Hisun Recent Development
Table 121. SL PHARM Company Details
Table 122. SL PHARM Business Overview
Table 123. SL PHARM Product
Table 124. SL PHARM Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 125. SL PHARM Recent Development
Table 126. Nanjing Hicin Company Details
Table 127. Nanjing Hicin Business Overview
Table 128. Nanjing Hicin Product
Table 129. Nanjing Hicin Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 130. Nanjing Hicin Recent Development
Table 131. Hongsheng Company Details
Table 132. Hongsheng Business Overview
Table 133. Hongsheng Product
Table 134. Hongsheng Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 135. Hongsheng Recent Development
Table 136. CINKATE CORPORATION Company Details
Table 137. CINKATE CORPORATION Business Overview
Table 138. CINKATE CORPORATION Product
Table 139. CINKATE CORPORATION Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 140. CINKATE CORPORATION Recent Development
Table 141. Huitian Company Details
Table 142. Huitian Business Overview
Table 143. Huitian Product
Table 144. Huitian Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 145. Huitian Recent Development
Table 146. Sinopharm ChuanKang Pharmaceutical Company Details
Table 147. Sinopharm ChuanKang Pharmaceutical Business Overview
Table 148. Sinopharm ChuanKang Pharmaceutical Product
Table 149. Sinopharm ChuanKang Pharmaceutical Revenue in Organ Transplant Immunosuppreant Business (2015-2020) (Million US$)
Table 150. Sinopharm ChuanKang Pharmaceutical Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Organ Transplant Immunosuppreant Market Share by Type: 2020 VS 2026
Figure 2. Selective Inhibitor of Cytokine Production And Function Features
Figure 3. Immunosuppressive Antimetabolites Features
Figure 4. Immunosuppressive Antibodies Features
Figure 5. Immunosuppressive Adrenocorticosteroids Features
Figure 6. Global Organ Transplant Immunosuppreant Market Share by Application: 2020 VS 2026
Figure 7. Kidney Transplantation Case Studies
Figure 8. Liver Transplantation Case Studies
Figure 9. Heart Transplantation Case Studies
Figure 10. Lung Transplantation Case Studies
Figure 11. Pancreas Transplantation Case Studies
Figure 12. Organ Transplant Immunosuppreant Report Years Considered
Figure 13. Global Organ Transplant Immunosuppreant Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Organ Transplant Immunosuppreant Market Share by Regions: 2020 VS 2026
Figure 15. Global Organ Transplant Immunosuppreant Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Organ Transplant Immunosuppreant Market Share by Players in 2019
Figure 18. Global Top Organ Transplant Immunosuppreant Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppreant as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Organ Transplant Immunosuppreant Revenue in 2019
Figure 20. North America Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Organ Transplant Immunosuppreant Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Astellas Pharma Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 33. Wyeth(Pfizer) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Wyeth(Pfizer) Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 35. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GlaxoSmithKline Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 37. Genzyme (Sanofi) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Genzyme (Sanofi) Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 39. Huadong Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Huadong Pharmaceutical Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 41. North China Pharmaceutical Huasheng Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. North China Pharmaceutical Huasheng Co. Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 43. Hisun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Hisun Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 45. SL PHARM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. SL PHARM Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 47. Nanjing Hicin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Nanjing Hicin Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 49. Hongsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Hongsheng Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 51. CINKATE CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CINKATE CORPORATION Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 53. Huitian Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Huitian Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 55. Sinopharm ChuanKang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sinopharm ChuanKang Pharmaceutical Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed